Aveanna Healthcare LLC 'B-' Issuer Credit Rating Affirmed; Debt Ratings Assigned - S&P Global Ratings’ Credit Research

Aveanna Healthcare LLC 'B-' Issuer Credit Rating Affirmed; Debt Ratings Assigned

Aveanna Healthcare LLC 'B-' Issuer Credit Rating Affirmed; Debt Ratings Assigned - S&P Global Ratings’ Credit Research
Aveanna Healthcare LLC 'B-' Issuer Credit Rating Affirmed; Debt Ratings Assigned
Published Nov 21, 2019
3 pages (1745 words) — Published Nov 21, 2019
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

Pediatric home care provider Aveanna Healthcare LLC plans to acquire Maxim Health Service Inc.'s home care services division for $1.16 billion, partially funded with $805 million in new debt, consisting of $560 million in additional first-lien debt and $245 million in an additional second-lien term loan. We are affirming our 'B-' issuer credit rating on Aveanna Healthcare, reflecting our view that the increased scale and business diversity following the acquisition is largely offset by heightened integration risk and leverage of about 8.1x in 2020 and 7.2x in 2021. We are assigning our 'B-' issue-level rating to the proposed $560 million senior secured first-lien debt. The recovery rating is '3', indicating our expectation for meaningful recovery (50%-70%; rounded estimate: 55%) in

  
Brief Excerpt:

...November 21, 2019 - Pediatric home care provider Aveanna Healthcare LLC plans to acquire Maxim Health Service Inc.'s home care services division for $1.16 billion, partially funded with $805 million in new debt, consisting of $560 million in additional first-lien debt and $245 million in an additional second-lien term loan. - We are affirming our 'B-' issuer credit rating on Aveanna Healthcare, reflecting our view that the increased scale and business diversity following the acquisition is largely offset by heightened integration risk and leverage of about 8.1x in 2020 and 7.2x in 2021. - We are assigning our 'B-' issue-level rating to the proposed $560 million senior secured first-lien debt. The recovery rating is '3', indicating our expectation for meaningful recovery (50%-70%; rounded estimate: 55%) in the event of a payment default. - We are assigning a '###' issue-level rating to the proposed $410 million second-lien term loan. The recovery rating is '6', indicating our expectation...

  
Report Type:

Ratings Action

Issuer
GICS
Specialized Finance (40201040)
Sector
Global Issuers
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Aveanna Healthcare LLC 'B-' Issuer Credit Rating Affirmed; Debt Ratings Assigned" Nov 21, 2019. Alacra Store. May 26, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Aveanna-Healthcare-LLC-B-Issuer-Credit-Rating-Affirmed-Debt-Ratings-Assigned-2345352>
  
APA:
S&P Global Ratings’ Credit Research. (). Aveanna Healthcare LLC 'B-' Issuer Credit Rating Affirmed; Debt Ratings Assigned Nov 21, 2019. New York, NY: Alacra Store. Retrieved May 26, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Aveanna-Healthcare-LLC-B-Issuer-Credit-Rating-Affirmed-Debt-Ratings-Assigned-2345352>
  
US$ 150.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.